The pursuit of purity is paramount in pharmaceutical manufacturing, directly impacting the safety and efficacy of medications. For drugs like Lurasidone, a key antipsychotic, the purity of its intermediates is non-negotiable. Central to the synthesis of Lurasidone is the compound (1R,2R)-1,2-cyclohexanedicarboxylic acid, known by its CAS number 46022-05-3. Its role as a precisely structured chiral precursor makes it indispensable in achieving the desired molecular architecture for the final API.

The production of Lurasidone involves a complex series of chemical reactions, and utilizing an intermediate with high enantiomeric purity, such as (1R,2R)-1,2-cyclohexanedicarboxylic acid, is crucial. This compound provides the necessary stereochemical foundation, ensuring that the subsequent steps in the synthesis proceed efficiently and yield the correct isomer of Lurasidone. Without this specific chiral configuration, the resulting drug might be less effective or could even possess unwanted side effects. Therefore, the quality and purity of (1R,2R)-1,2-cyclohexanedicarboxylic acid directly translate to the quality of the final pharmaceutical product.

NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to upholding the highest standards in supplying critical pharmaceutical intermediates. Our commitment to providing high purity cyclohexanedicarboxylic acid ensures that our clients in the pharmaceutical sector have access to materials that meet stringent regulatory requirements. The meticulous attention to detail in the synthesis and quality control of CAS 46022-05-3 is a testament to our role as a reliable partner in the pharmaceutical supply chain.

The significance of (1R,2R)-1,2-cyclohexanedicarboxylic acid is further amplified by the growing demand for treatments for mental health conditions like schizophrenia and bipolar disorder. As these conditions require consistent and effective therapeutic interventions, the reliable supply of essential intermediates like this dicarboxylic acid is vital. NINGBO INNO PHARMCHEM CO.,LTD. plays a key role in this ecosystem by ensuring the availability of this compound for manufacturers aiming to meet global healthcare needs.

In essence, the purity and specific chirality of (1R,2R)-1,2-cyclohexanedicarboxylic acid are not mere chemical specifications; they are fundamental requirements for the successful and safe production of Lurasidone. NINGBO INNO PHARMCHEM CO.,LTD. remains committed to delivering the quality and reliability that the pharmaceutical industry demands, supporting the development of advanced therapeutic solutions.